Akero Therapeutics is a clinical-stage biotech company focused on developing innovative treatments for serious metabolic diseases like MASH. Their lead product candidate, EFX, is currently being tested in multiple Phase 2b and Phase 3 clinical trials for patients with cirrhosis or pre-cirrhotic conditions due to MASH. Headquartered in South San Francisco, Akero aims to address high unmet medical needs through cutting-edge research and development.
Akero Therapeutics is seeking a Senior Quality Assurance (QA) Representative to oversee outsourced drug substance, drug product, and quality control (QC) testing operations within a fully outsourced, virtual company model. The role focuses on ensuring compliance with global GMP requirements, regulatory oversight, and inspection readiness. This individual will serve as a primary quality interface between internal stakeholders and external partners.
Akero Therapeutics is a clinical-stage biotech company focused on developing innovative treatments for serious metabolic diseases like MASH. Their lead product candidate, EFX, is currently being tested in multiple Phase 2b and Phase 3 clinical trials for patients with cirrhosis or pre-cirrhotic conditions due to MASH. Headquartered in South San Francisco, Akero aims to address high unmet medical needs through cutting-edge research and development.
Akero Therapeutics